BRÈVE

sur ABIONYX (EPA:ABNX)

ABIONYX Announces February Voting Rights Update

Graphique de l'évolution du cours de l'action ABIONYX (EPA:ABNX).

ABIONYX Pharma has released its monthly update on total voting rights and shares comprising the company's capital as of February 28, 2026. Listed on Euronext Paris, Compartment C, the company's ISIN code is FR0012616852. This report complies with Article L233-8-II of the French Commercial Code and Article 223-16 of the AMF's General Regulations.

As of the end of February, ABIONYX reported 35,511,655 shares outstanding. The total number of gross voting rights amounted to 45,090,893, while the total net voting rights were 44,842,154. The gross figure is used to calculate threshold crossings and includes all shares with voting rights, even those suspended. The net figure excludes shares with suspended voting rights to inform the public accurately, following an AMF recommendation from July 2007.

R. H.

Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de ABIONYX